HIV diversity, recombination and disease progression: How does fitness "fit" into the puzzle?

AIDS Reviews

Volumn 9, Issue 2, 2007, Pages 75-87

  Tebit, Denis M ^a   Nankya, Immaculate ^a   Arts, Eric J ^a   Gao, Yong ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Disease progression; HIV subtype; Recombination; Viral fitness

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GAG PROTEIN; GLYCOPROTEIN GP 120; NEF PROTEIN; POL PROTEIN; VIRUS ENVELOPE PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BOTTLENECK POPULATION; DISEASE COURSE; EPIDEMIC; FOUNDER EFFECT; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR EVOLUTION; NONHUMAN; PHENOTYPE; PHYLOGENETIC TREE; PREVALENCE; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; STRAIN DIFFERENCE; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS PATHOGENESIS; VIRUS RECOMBINATION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS TYPING;

DISEASE PROGRESSION; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; RECOMBINATION, GENETIC; VARIATION (GENETICS);

EID: 34547402539     PISSN: 11396121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (133)

1. Ho D, Neumann A, Perelson A, Chen W, Leonard J, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
2. Wei X, Ghosh S, Taylor M, et al. Viral dynamics in HIV type 1 infection. Nature 1995;373:117-22.
3. Preston B, Poiesz B, Loeb L. Fidelity of HIV-1 reverse transcriptase. Science 1988;242:1168-71.
4. Preston B, Dougherty J. Mechanisms of retroviral mutation. Trends Microbiol 1996;4:16-21.
5. Hu W, Temin H. Retroviral recombination and reverse transcription. Science 1990;250:1227-33.
6. Burke D. Recombination in HIV: an important viral evolutionary strategy. Emerg Infect Dis 1997;3:253-9.
7. Temin H. Retrovirus variation and reverse transcription: abnormal strand transfers result in retrovirus genetic variation. Proc Natl Acad Sci USA 1993;90:6900-3.
8. Wain-Hobson S. HIV-1 quasispecies in vivo and ex vivo. Curr Top Microbiol Immunol 1992;176:181-93.
9. Domingo E, Holland J. RNA virus mutations and fitness for survival. Annu Rev Microbiol 1997;51:151-78.
10. Shankarappa R, Margolick J, Gange S, et al. Consistent viral evolutionary changes associated with the progression of HIV-1 infection. J Virol 1999;73:10489-502.
11. Hirsch V, Olmsted R, Murphey-Corb M, Purcell R, Johnson P. An African primate lentivirus (SIVsm) closely related to HIV-2. Nature 1989;339:389-92.
12. Santiago M, Rodenburg C, Kamenya S, et al. SIVcpz in wild chimpanzees. Science 2002;295:465.
13. Gao F, Bailes E, Robertson D, et al. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999;397:436-41.
14. Calli B, Van H, Li Y, et al. Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science 2006;313:523-6.
15. Van H, Li Y, Neel C, et al. Human immunodeficiency viruses: SIV infection in wild gorillas. Nature 2006;444:164.
16. Korber B, Muldoon M, Theiler J, et al. Timing the ancestor of the HIV-1 pandemic strains. Science 2000;288:1789-96.
17. Salemi M, Strimmer K, Hall W, et al. Dating the common ancestor of SIVcpz and HIV-1 group M and the origin of HIV-1 subtypes using a new method to uncover clock-like molecular evolution. FASEB J 2001;15:276-8.
18. Lemey P, Pybus O, Wang B, Saksena N, Salemi M, Vandamme AM. Tracing the origin and history of the HIV-2 epidemic. Proc Natl Acad Sci USA 2003;100:6588-92.
19. Gao F, Robertson D, Carruthers C, et al. A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of HIV type 1. J Virol 1998;72:5680-98.
20. Takehisa J, Zekeng L, Miura T, et al. Triple HIV-1 infection with group O and Group M of different clades in a single Cameroonian AIDS patient. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:81-2.
21. Takehisa J, Zekeng L, Ido E, et al. Various types of HIV mixed infections in Cameroon. Virology 1998;245:1-10.
22. Tebit D, Zekeng L, Kaptue L, Salminen M, Krausslich H, Herchenroder O. Genotypic and phenotypic analysis of HIV-1 primary isolates from western Cameroon. AIDS Res Hum Retroviruses 2002; 18:39-48.
23. Carr J, Salminen M, Koch C, et al. Full-length sequence and mosaic structure of a HIV-1 isolate from Thailand. J Virol 1996; 70:5935-43.
24. Jonassen T, Stene-Johansen K, Berg E, et al. Sequence analysis of HIV-1 group O from Norwegian patients infected in the 1960s. Virology 1997;231:43-7.
25. Gurtler L, Hauser P, Eberle J, et al. A new subtype of HIV-1 (MVP-5180) from Cameroon. J Virol 1994;68:1581-5.
26. Quinones-Mateu M, Albright J, Mas A, Soriano V, Arts E. Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of HIV-1. J Virol 1998; 72:9002-15.
27. Mas A, Quinones-Mateu M, Domingo E, Soriano V. Phylogeny of HIV-1 group O isolates based on env gene sequences. AIDS Res Hum Retroviruses 1999;15:769-73.
28. Janssens W, Heyndrickx L, van der Auwera G, et al. Inter-patient genetic variability of HIV-1 group O. AIDS 1999;13:41-8.
29. Roques P, Robertson D, Souquiere S, et al. Phylogenetic analysis of 49 newly derived HIV-1 group O strains: high viral diversity but no group M-like subtype structure. Virology 2002;302:259-73.
30. Yamaguchi J, Vallari A, Swanson P, et al. Evaluation of HIV-1 group O isolates: identification of five phylogenetic clusters. AIDS Res Hum Retroviruses 2002;18:269-82.
31. Yamaguchi J, Bodelle P, Kaptue L, et al. Near full-length genomes of 15 HIV-1 group O isolates. AIDS Res Hum Retroviruses 2003; 19:979-88.
32. Corbet S, Muller-Trutwin M, Versmisse P, et al. env sequences of SIV from chimpanzees in Cameroon are strongly related to those of HIV group N from the same geographic area. J Virol 2000;74:529-34.
33. Apetrei C, Robertson D, Marx P. The history of SIVS and AIDS: epidemiology, phylogeny and biology of isolates from naturally SIV infected non-human primates (NHP) in Africa. Front Biosci 2004; 9:225-54.
34. Gao F, Yue L, Robertson D, et al. Genetic diversity of HIV-2: evidence for distinct sequence subtypes with differences in virus biology. J Virol 1994;68:7433-47.
35. Damond F, Worobey M, Campa P, et al. Identification of a highly divergent HIV-2 and proposal for a change in HIV-2 classification. AIDS Res Hum Retroviruses 2004;20:666-72.
36. Leitner T, Escanilla D, Marquina S, et al. Biological and molecular characterization of subtype D, G, and A/D recombinant HIV-1 transmissions in Sweden. Virology 1995;209:136-46.
37. Sabino E, Shpaer E, Morgado M, et al. Identification of HIV-1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil. J Virol 1994;68:6340-6.
38. Robertson D, Sharp P, MeCutchan F, Hahn B. Recombination in HIV-1. Nature 1995;374:124-6.
39. Sharp P, Robertson D, Hahn B. Cross-species transmission and recombination of 'AIDS' viruses. Philos Trans R Soc Lond B Biol Sci 1995;349:41-7.
40. Robertson D, Anderson J, Bradac J, et al. HIV-1 nomenclature proposal. Science 2000;288:55-6.
41. HIV Sequence Database. Theoretical Biology and Biophysics Group. Los Alamos National Laboratory. Los Alamos, NM. 2007.
42. Peeters M, Sharp P. Genetic diversity of HIV-1: the moving target. AIDS 2000;14 (Suppl 3):129-40.
43. Takehisa J, Zekeng L, Ido E, et al. HIV-1 intergroup (M/O) recombination in Cameroon. J Virol 1999;73:6810-20.
44. Peeters M, Liegeois F, Torimiro N, et al. Characterization of a highly replicative intergroup M/O HIV-1 recombinant isolated from a Cameroonian patient. J Virol 1999;73:7368-75.
45. Yamaguchi J, Bodelle P, Vallari A, et al. HIV infections in northwestern Cameroon: identification of HIV-1 group O and dual HIV-1 group M and group O infections. AIDS Res Hum Retroviruses 2004;20:944-57.
46. Peeters M, Delaporte E. Genetic diversity of HIV infection worldwide and its consequences. Med Trop 1999;59:449-55.
47. Kanki P, Peeters M, Gueye-Ndiaye A. Virology of HIV-1 and HIV-2: implications for Africa. AIDS 1997; 11(Suppl B):33.42.
48. UNAIDS 2006. AIDS Epidemic update, 2006.
49. Ghys P, Saidel T, Vu H, et al. Growing in silence: selected regions and countries with expanding HIV/AIDS epidemics. AIDS 2003; 17(Suppl 4):45-60.
50. Hoelscher M, Hanker S, Barin F, et al. HIV type 1 V3 serotyping of Tanzanian samples: probable reasons for mismatching with genetic subtyping. AIDS Res Hum Retroviruses 1998;14:139-49.
51. Kiwelu I, Koulinska I, Nkya W, Shao J, Kapiga S, Essex M. Identification of CRF10_CD viruses among bar and hotel workers in Moshi, Northern Tanzania. AIDS Res Hum Retroviruses 2005;21: 897-900.
52. Zhu T, Korber B, Nahmias A, Hooper E, Sharp P, Ho D. An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. Nature 1998;391:694-7.
53. Vidal N, Peeters M, Mulanga-Kabeya C, et al. Unprecedented degree of HIV-1 group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa. J Virol 2000;74:10498-507.
54. Kane C, Montavon C, Toure M, et al. Full-length genome sequencing of HIV-1 group O viruses isolated from a heterosexual transmission cluster in Senegal. AIDS Res Hum Retroviruses 2001; 17:1211-6.
55. Rayfield M, Sullivan P, Bandea C, et al. HIV-1 group O virus identified for the first time in the United States. Emerg Infect Dis 1996;2:209-12.
56. Hampl H, Sawitzky D, Stoffler-Meilicke M, et al. First case of HIV-1 subtype 0 infection in Germany. Infection 1995;23:369-70.
57. Loussert-Ajaka I, Chaix M, Korber B, et al. Variability of HIV-1 group O strains isolated from Cameroonian patients living in France. J Virol 1995;69:5640-9.
58. Peeters M, Esu-Williams E, Vergne L, et al. Predominance of subtype A and G HIV-1 in Nigeria, with geographical differences in their distribution. AIDS Res Hum Retroviruses 2000;16:315-25.
59. Vergne L, Bourgeois A, Mpoudi-Ngole E, et al. Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage. Virology 2003;310:254-66.
60. Ndembi N, Takehisa J, Zekeng L, et al. Genetic diversity of HIV-1 in rural eastern Cameroon. J Acquir Immune Defic Syndr 2004; 37:1641-50.
61. Burda S, Konings F, Williams C, Anyangwe C, Nyambi P. HIV-1 CRF09∐x circulates in the North West Province of Cameroon where CRF02_AG infections predominate and recombinant strains are common. AIDS Res Hum Retroviruses 2004;20:1358-63.
62. Konings F, Haman G, Xue Y, et al. Genetic analysis of HIV-1 strains in rural eastern Cameroon indicates the evolution of second-generation recombinants to circulating recombinant forms. J Acquir Immune Defic Syndr 2006;42:331-41.
63. Tebit D, Ganame J, Sathiandee K, Nagabila Y, Coulibaly B, Krausslich H. Diversity of HIV in rural Burkina Faso. J Acquir Immune Defic Syndr 2006;43:144-52.
64. Oelrichs R, Workman C, Laukkanen T, McCutchan F, Deacon N. A novel subtype A/G/J recombinant full-length HIV-1 genome from Burkina Faso. AIDS Res Hum Retroviruses 1998;14:1495-500.
65. Mamadou S, Vidal N, Montavon C, et al. Emergence of complex and diverse CRF02-AG/CRF06-cpx recombinant HIV-1 strains in Niger, West Africa. AIDS Res Hum Retroviruses 2003;19:77-82.
66. Shankarappa R, Chatterjee R, Learn G, et al. HIV-1 env sequences from Calcutta in eastern India: identification of features that distinguish subtype C sequences in India from other subtype C sequences. J Virol 2001;75:10479-87.
67. Siddappa N, Dash P, Mahadevan A, et al. Identification of subtype C HIV-1 by subtype-specific PCR and its use in the characterization of viruses circulating in the southern parts of India. J Clin Microbiol 2004;42:2742-51.
68. Lole K, Bollinger R, Paranjape R, et al. Full-length HIV-1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 1999;73:152-60.
69. Mandal D, Jana S, Panda S, et al. Distribution of HIV-1 subtypes in female sex workers of Calcutta, India. Indian J Med Res 2000; 112:165-72.
70. Bobkov A, Kazennova E, Selimova L, et al. Temporal trends in the HIV-1 epidemic in Russia: predominance of subtype A. J Med Virol 2004;74:191-6.
71. Liitsola K, Tashkinova I, Laukkanen T, et al. HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad. AIDS 1998;12:1907-19.
72. Hemelaar J, Gouws E, Ghys P, Osmanov S. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 2006;20:13-23.
73. Perez-Alvarez L, Munoz M, Delgado E, et al. Isolation and biological characterization of HIV-1 BG intersubtype recombinants and other genetic forms circulating in Galicia, Spain. J Med Virol 2006;78:1520-8.
74. Lawrence P, Lutz M, Saoudin H, et al. Analysis of polymorphism in the protease and reverse transcriptase genes of HIV-1 CRF02-AG subtypes from drug-naive patients from Saint-Etienne, France. J Acquir Immune Defic Syndr 2006;42:396-404.
75. Aggarwal I, Smith M, Tatt I, et al. Evidence for onward transmission of HIV-1 non-B subtype strains in the United Kingdom. J Acquir Immune Defic Syndr 2006;41:201-9.
76. Parreira R, Padua E, Piedade J, Venenno T, Paixao M, Esteves A. Genetic analysis of HIV-1 nef in Portugal: subtyping, identification of mosaic genes, and amino acid sequence variability. J Med Virol 2005;77:8-16.
77. Smallman-Raynor M, Cliff A. The spread of HIV-2 into Europe: a geographical analysis. Int J Epidemiol 1991;20:480-9.
78. Aulicino P, Kopka J, Mangano A, et al. Circulation of novel HIV-1 A, B/ C, and F subtypes in Argentina. AIDS Res Hum Retroviruses 2005;21:158-64.
79. Carr J, Avila M, Gomez C, et al. Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America. AIDS 2001;15:F41-7.
80. Carrion G, Eyzaguirre L, Montano S, et al. Documentation of subtype C HIV-1 strains in Argentina, Paraguay, and Uruguay. AIDS Res Hum Retroviruses 2004;20:1022-5.
81. Soares E, Martinez A, Souza T, et al. HIV-1 subtype C dissemination in southern Brazil. AIDS 2005;19(Suppl 4):S81-6.
82. Cuevas M, Ruibal I, Villahermosa ML, et al. High HIV-1 genetic diversity in Cuba. AIDS 2002;16:1643-53.
83. Quinones-Mateu M, Ball S, Marozsan A, et al. A dual infection/ competition assay shows a correlation between ex vivo HIV-1 fitness and disease progression. J Virol 2000;74:9222-33.
84. Troyer R, Collins K, Abraha A, et al. Changes in HIV-1 fitness and genetic diversity during disease progression. J Virol 2005; 79:9006-18.
85. Njai H, Gali Y, Vanham G, et al. The predominance of HIV-1 circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness. Retrovirology 2006;3:40-6.
86. Konings F, Burda S, Urbanski M, Zhong P, Nadas A, Nyambi P. HIV-1 circulating recombinant form 02_AG (CRF02_AG) has a higher in vitro replicative capacity than its parental subtypes A and G. J Med Virol 2006;78:523-34.
87. Deacon N, Tsykin A, Solomon A, et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 1995;270:988-91.
88. Kirchhoff F, Greenough T, Brettler D, Sullivan J, Desrosiers R. Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 1996;332:228-32.
89. Huang Y, Zhang L, Ho D. Biological characterization of nef in longterm survivors of HIV-1 infection. J Virol 1995;69:8142-6.
90. Novella I, Quer J, Domingo E, Holland J. Exponential fitness gains of RNA virus populations are limited by bottleneck effects. J Virol 1999;73:1668-71.
91. Blauvelt A, Glushakova S, Margolis L. HIV-infected human Langerhans cells transmit infection to human lymphoid tissue ex vivo. AIDS 2000;14:647-51.
92. Overbaugh J, Kreiss J, Poss M, et al. Studies of HIV-1 mucosal viral shedding and transmission in Kenya. J Infect Dis 1999;179 (Suppl 3):401-4.
93. Long E, Martin H, Kreiss J, et al. Gender differences in HIV-1 diversity at time of infection. Nat Med 2000;6:71-5.
94. Berger E, Murphy P, Farber J. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 1999;17:657-700.
95. Coffin J. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 1995;267:483-9.
96. Tersmette M, Lange J, de Goede R, et al. Association between biological properties of HIV variants and risk for AIDS and AIDS mortality. Lancet 1989;1:983-5.
97. Tscherning C, Alaeus A, Fredriksson R, et al. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology 1998;241:181-8.
98. Brown B, Darden J, Tovanabutra S, et al. Biologic and genetic characterization of a panel of 60 HIV-1 isolates, representing clades A, B, C, D, CRF01Æ, and CRF02_AG, for the development and assessment of candidate vaccines. J Virol 2005;79:6089-101.
99. Mellors J, Rinaldo C, Gupta P, White R, Todd J, Kingsley L. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.
100. Rodriguez B, Sethi A, Cheruvu V, et al. Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 2006;296:1498-506.
101. Ball S, Abraha A, Collins K, et al. Comparing the ex vivo fitness of CCR5-tropic HIV-1 isolates of subtypes Band C. J Virol 2003; 77:1021-38.
102. Nijhuis M, Schuurman R, de Jong D, et al. Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy. AIDS 1999;13:2349-59.
103. Rangel H, Weber J, Chakraborty B, et al. Role of the HIV-1 envelope gene in viral fitness. J Virol 2003;77:9069-73.
104. Borrow P, Lewicki H, Wei X, et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med 1997;3:205-11.
105. Jensen M, Li F, van 't Wout A, et al. Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of HIV-1 env V3 loop sequences. J Virol 2003;77:13376-88.
106. Overbaugh J, Bangham C. Selection forces and constraints on retroviral sequence variation. Science 2001;292:1106-9.
107. Richman D, Wrin T, Little S, Petropoulos C. Rapid evolution of the neutralizing antibody response to HIV-1 infection. Proc Natl Acad Sci USA 2003;100:4144-9.
108. Arien K, Abraha A, Quinones-Mateu M, Kestens L, Vanham G, Arts E. The replicative fitness of primary HIV-1 group M, HIV-1 group O, and HIV-2 isolates. J Virol 2005;79:8979-90.
109. Schim van der Loeff M, Aaby P. Towards a better understanding of the epidemiology of HIV-2. AIDS 1999;13(Suppl A):69-84.
110. Marlink R, Kanki P, Thior I, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994; 265:1587-90.
111. Matheron S, Pueyo S, Damond F, et al. Factors associated with clinical progression in HIV-2 infected-patients: the French ANRS cohort. AIDS 2003;17:2593-601.
112. Gilbert P, McKeague I, Eisen G, et al. Comparison of HIV-1 and HIV-2 infectivity from a prospective cohort study in Senegal. Stat Med 2003;22:573-93.
113. Kanki P, Travers K, Mboup S, et al. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 1994;343:943-6.
114. Ayouba A, Souquieres S, Njinku B, et al. HIV-1 group N among HIV-1-seropositive individuals in Cameroon. AIDS 2000;14:2623-5.
115. Ayouba A, Mauclere P, Martin P, et al. HIV-1 group O infection in Cameroon, 1986 to 1998. Emerg Infect Dis 2001;7:466-7.
116. Nkengasong J, Fransen K, Willems B, et al. Virologic, immunologic, and clinical follow-up of a couple infected by the HIV-1 group O. J Med Virol 1997;51:202-9.
117. Blauvelt A, Asada H, Saville M, et al. Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways. J Clin Invest 1997;100: 2043-53.
118. Dittmar M, Simmons G, Hibbitts S, et al. Langerhans cell tropism of HIV-1 subtype A through F isolates derived from different transmission groups. J Virol 1997;71:8008-13.
119. Pope M, Ho D, Moore J, Weber J, Dittmar M, Weiss R. Different subtypes of HIV-1 and cutaneous dendritic cells. Science 1997; 276:786-8.
120. Sivard P, Berlier W, Picard B, Sabido O, Genin C, Misery L. HIV-1 infection of Langerhans cells in a reconstructed vaginal mucosa. J Infect Dis 2004;190:227-35.
121. Harris M, Maayan S, Kim B, et al. A cluster of HIV-1 subtype C sequences from Ethiopia, observed in full genome analysis, is not sustained in subgenomic regions. AIDS Res Hum Retroviruses 2003;19:1125-33.
122. Grez M, Dietrich U, Balfe P, et al. Genetic analysis of HIV-1 and HIV-2 mixed infections in India reveals a recent spread of HIV-1 and HIV-2 from a single ancestor for each of these viruses. J Virol 1994;68:2161-8.
123. Vidal N, Mulanga C, Bazepeo S, et al. Distribution of HIV-1 variants in the Democratic Republic of Congo suggests increase of subtype C in Kinshasa between 1997 and 2002. J Acquir Immune Defic Syndr 2005;40:456-62.
124. Rainwater S, DeVange S, Sagar M, et al. No evidence for rapid subtype C spread within an epidemic in which multiple subtypes and intersubtype recombinants circulate. AIDS Res Hum Retroviruses 2005;21:1060-5.
125. Hunt G, Tiemessen C. Occurrence of additional NF-kappaB-binding motifs in the long terminal repeat region of South African HIV-1 subtype C isolates. AIDS Res Hum Retroviruses 2000;16:305-6.
126. van Hermelen J, Williamson C, Kim B, et al. Characterization of full-length HIV-1 subtype C sequences from South Africa. AIDS Res Hum Retroviruses 2001;17:1527-31.
127. Centlivre M, Sommer P, Michel M, et al. HIV-1 clade promoters strongly influence spatial and temporal dynamics of viral replication in vivo. J Clin Invest 2005;115:348-58.
128. Centlivre M, Sommer P, Michel M, et al. The HIV-1 clade C promoter is particularly well adapted to replication in the gut in primary infection. AIDS 2006;20:657-66.
129. Cecilia D, Kulkarni S, Tripathy S, Gangakhedkar R, Paranjape R, Gadkari D. Absence of coreceptor switch with disease progression in HIV infections in India. Virology 2000;271:253-8.
130. Nankya I, Abraha A, Fraundorf E, et al. The HIV-1 envelope gene determines viral fitness in both drug sensitive and resistant isolates. XVI International AIDS conference. Toronto, Canada 2006 [abstract Thlb0306].
131. Yang C, Dash B, Hanna S, et al. Predominance of HIV-1 subtype G among commercial sex workers from Kinshasa, Democratic Republic of Congo. AIDS Res Hum Retroviruses 2001;17:361-5.
132. Pybus O, Rambaut A, Harvey P. An integrated framework for the inference of viral population history from reconstructed genealogies. Genetics 2000;155:1429-37.
133. Turk G, Carobene M, Monczor A, Rubio A, Gomez-Carrillo M, Salomon H. Higher transactivation activity associated with LTR and Tat elements from HIV-1 BF intersubtype recombinant variants. Retrovirology 2006;3:14-9.